Treatment of systemic lupus erythematosus.
D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008775:Methylprednisolone / Q000627:therapeutic use; D010956:Plasmapheresis; D013256:Steroids / Q000627:therapeutic use
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D013256:Steroids; D006886:Hydroxychloroquine; D003520:Cyclophosphamide; D001379:Azathioprine; D008775:Methylprednisolone